Study early warning signs in relapsing-remitting multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at “subclinical markers,” meaning early or hidden body changes that may show how relapsing-remitting multiple sclerosis (MS) is doing even when symptoms seem mild. It may help researchers find better ways to monitor MS and detect changes sooner.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with relapsing-remitting multiple sclerosis (RRMS)
- Your MS disability level is low, roughly EDSS 0 to 3.5 (mild to moderate function)
- You do not have metal in your body (for example, a pacemaker or metal dental work like dentures)
- You are not currently newly pregnant, and you can confirm pregnancy status if needed
- You have not recently had a head injury
- You agree to sign consent and follow the study steps
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether people with relapsing-remitting MS can experience symptom flare-ups (relapses) that don't show up on MRI scans. Researchers want to understand if this happens and what it means for your care.
This study follows adults with relapsing-remitting multiple sclerosis using MRI scans and blood tests. It aims to understand how the disease behaves and what markers in blood and imaging may relate to changes over time.
This study looks at people who are at higher risk for multiple sclerosis (MS), to better understand early changes before MS is diagnosed. It may help doctors identify who is more likely to develop MS and how to monitor them sooner.
This study looks at how certain brain changes relate to disability in people with multiple sclerosis (MS). It aims to see if measuring brain volume loss can help predict disease progression, which might help tailor treatments.
This study looks at why some people with relapsing-remitting multiple sclerosis (RRMS) get worse even when they don't have relapses. It uses eye scans and other tests to find early signs of progression, which could help tailor treatments.
This trial uses brain MRI and eye imaging tests to study research markers in people with multiple sclerosis (MS) and related neurologic conditions. It may help researchers better understand these diseases and how they change over time.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.